Zinger Key Points
- HCA Healthcare Q4 revenues reached $18.29B, surpassing the $18.23B consensus, with adjusted EPS of $6.22, up from $5.90 YoY.
- 2025 guidance includes EPS of $24.05-$25.85 and sales of $72.8B-$75.8B, with capital expenditures projected at $5.0-$5.2B.
- Get Pro-Level Earnings Insights Before the Market Moves
On Friday, HCA Healthcare Inc. HCA reported fourth-quarter revenues of $18.29 billion, up 5.7% year-over-year, slightly above the consensus of $18.23 billion.
The hospital chain reported adjusted EPS of $6.22, up from $5.90 a year ago, surpassing the consensus of $6.13.
In the fourth quarter of 2024, same-facility admissions increased 3% year over year, while same-facility equivalent admissions increased 3.1%.
Same-facility emergency room visits increased by 2.4%, same-facility inpatient surgeries increased by 2.8%, and same-facility outpatient surgeries declined by 1.3%.
Same facility revenue per equivalent admission increased by 2.9%. For the fourth quarter of 2024, adjusted EBITDA totaled $3.71 billion, compared to $3.62 billion a year ago.
During the fourth quarter of 2024, the company incurred additional expenses and experienced loss of revenues estimated at $200 million, or $0.60 per diluted share, associated with Hurricane Helene’s impact on its North Carolina facilities, as well as from Hurricane Milton, which impacted certain facilities in Florida.
HCA Healthcare’s board has authorized an additional share repurchase program for up to $10 billion.
HCA declared a quarterly cash dividend of $0.72 per share on its common stock, up from the $0.66 dividend paid in December. The dividend will be paid on March 31 to stockholders of record at the close of business on March 17, 2025.
Guidance: HCA Healthcare forecasts 2025 EPS of $24.05-$25.85 versus a consensus of $24.58, with a sales outlook of $72.8 billion-$75.8 billion versus a consensus of $74.76 billion.
The company expects a 2025 net profit of $5.85 billion-$6.29 billion and adjusted EBITDA of $14.30 billion—$15.10 billion.
Capital expenditures for 2025, excluding acquisitions, are estimated to be approximately $5.0 billion to $5.2 billion.
Price Action: HCA Healthcare stock is down 0.463% at $323.86 at last check Friday.
Read Next:
Photo: raker/Shutterstock.com.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
